Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide mapping of H3K4me3 and H3K27ac in monocytes from SARS-CoV-2 convalescent patients.

ABSTRACT: Genome-wide mapping of H3K4me3 and H3K27ac in monocytes from SARS-CoV-2 convalescent patients.

PROVIDER: PRJNA726171 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14359364_1.fastq.gz	Fastqsanger.gz
	SRR14359364_2.fastq.gz	Fastqsanger.gz
	SRR14359365_1.fastq.gz	Fastqsanger.gz
	SRR14359365_2.fastq.gz	Fastqsanger.gz
	SRR14359366_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Genome-wide mapping of H3K4me3 and H3K27ac in monocytes from SARS-CoV-2 convalescent patients.

Project description:Epigenetic alterations of monocytes from COVID-19 convalescent individuals and healthy controls have been analyzed by mapping trimethylated H3K4 (H3K4me3) and acetylated H3K27 (H3K27ac) genome-wide using CUT&RUN (Skene & Henikoff, 2017). Epigenetic reprogramming of myeloid cells represents a hallmark of trained innate immunity (Netea, Joosten et al., 2016). In general, active enhancers are marked by H3K27ac and transcription start sites are marked by H3K4me3 and H3K27ac (Kimura, 2013). A global analysis of histone modifications associated with transcription start sites (TSS) revealed a difference in the overall coverage of specific loci in SC-conv versus SC-naïve cells with SC-conv samples showing lower occupancy overall

2021-06-07 | GSE173568 | GEO

H3K4me3 and H3K27ac ChIp-seq

Project description:H3K4me3 and H3K27ac ChIp-seq

| PRJNA512869 | ENA

Coronavirus antibody profiling in convalescent sera of RT-PCR SARS-CoV-2 confirmed hospitalised patients

Project description:Convalescent sera of RT-PCR SARS-CoV-2 confirmed hospitalised patients were tested on the protein array to profile IgG, IgM, and IgA antibody levels against human coronaviruses.

2022-03-08 | E-MTAB-11523 | biostudies-arrayexpress

Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients [RNA-seq]

Project description:Severe COVID-19 disease is associated with dysregulation of the myeloid compartment during acute infection. Survivors frequently experience long-lasting sequelae but little is known about the eventual persistence of this immune alteration. Herein, we evaluated Toll-like receptor-induced cytokine responses in a cohort of mild to critical patients during acute or convalescent phases (n=97). In the acute phase, we observed impaired cytokine production by monocytes in the most severe patients. This capacity was globally restored in convalescent patients. Yet, we observed increased responsiveness to TLR1/2 ligation in patients that recovered from severe disease, indicating that these cells display distinct functional properties at the different stages of the disease. We identified a specific transcriptomic and epigenomic state in monocytes from acute severe patients that can account for their functional refractoriness. The molecular profile of monocytes from recovering patients was distinct and characterized by increased chromatin accessibility at AP-1 and MAF loci. These results demonstrate that severe COVID-19 infection has a profound impact on the differentiation status and function of circulating monocytes both during the acute and the convalescent phases in a completely distinct manner. This could have important implications for our understanding of short and long-term COVID19-related morbidity.

2022-04-01 | GSE198256 | GEO

Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients [ATAC-seq]

2022-04-01 | GSE198255 | GEO

H3K4me3, H3K27ac, EZH2 in K562

Project description:ChIP-seq of K562 cells: H3K4me3, H3K27ac, EZH2

| PRJEB72776 | ENA

Linear epitope-specific IgG responses to SARS-CoV-2 and related human coronaviruses in human COVID-19 convalescent sera

Project description:The on-going COVID-19 pandemic requires a deeper understanding of the long-term antibody responses that persist following SARS-CoV-2 infection. To that end, we determined epitope-specific IgG antibody responses in COVID-19 convalescent sera collected at 5 months post-diagnosis and compared that to sera from naïve individuals. Each serum sample was reacted with a high-density peptide microarray representing the complete proteome of SARS-CoV-2 as 15 mer peptides with 11 amino acid overlap and homologs of spike glycoprotein, nucleoprotein, membrane protein, and envelope small membrane protein from related human coronaviruses. Binding signatures were compared between COVID-19 convalescent patients and naïve individuals using the web service tool EPIphany.

2022-02-05 | E-MTAB-10740 | biostudies-arrayexpress

Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation

Project description:We used single-cell RNA sequencing to analyze immune cells in COVID-19 patients. We drew blood from convalescent patients and examined PBMCs, monocytes and regulatory T cells.

2025-05-30 | GSE273137 | GEO

H3K27ac in SARS-CoV-2 infection

Project description:H3K27ac in SARS-CoV-2 infection

| PRJNA704898 | ENA

Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients

Project description:Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients

| PRJNA814288 | ENA